Awards & Advancement

Paul Fonteyne named president, CEO of Boehringer Ingelheim USA

Friday, February 10, 2012 11:42 AM

Paul R. Fonteyne has been promoted to U.S. country managing director and president and CEO of Boehringer Ingelheim USA. Fonteyne assumes this role from J. Martin Carroll, who remains with the company in a corporate strategy and development role and a member of the board.

More... »

Cleveland BioLabs announces management reorganization

Friday, February 10, 2012 11:39 AM

Cleveland BioLabs, a drug discovery and development company, has made a number of changes in corporate management responsibilities.

More... »

Dr. Saul Shiffman recognized by Carnegie awards

Tuesday, February 7, 2012 03:04 PM

Dr. Saul Shiffman, co-founder and chief science officer of invivodata, received an honorable mention in the entrepreneur category of the 2012 Carnegie Science Awards, which recognizes outstanding science and technology achievements in western Pennsylvania.

More... »

EntreMed names two to board of directors

Tuesday, February 7, 2012 01:07 PM

EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has appointed Wei-Wu He, Ph.D, executive chairman of its board of directors, and Tak W. Mak, Ph.D, as member of the board of directors.

More... »

Mount Sinai Medical Center appoints chair, board members

Monday, February 6, 2012 02:55 PM

Wayne E. Chaplin, president and COO of Southern Wine & Spirits of America, is the new chairman of the Mount Sinai Medical Center board of trustees. Chaplin previously served as the past vice chair of the executive committee at Mount Sinai.

More... »

Stephan Henauer to head i3 Pharma Resourcing in Europe

Monday, February 6, 2012 02:52 PM

PharmaNet/i3, inVentiv Health’s clinical segment, has appointed Stephan Henauer, M.D., executive director of i3 Pharma Resourcing. Henauer will lead the company’s staffing business in central, eastern and northern Europe.

More... »

HemoShear appoints Figler scientific director

Monday, February 6, 2012 02:50 PM

HemoShear, a biotechnology research company, has appointed Robert A. Figler, Ph.D., scientific director.

More... »

BioStat’s rED Cap software receives trademark status

Thursday, February 2, 2012 09:02 AM

BioStat International’s rED Cap, proprietary, web-based clinical trial data management software, has received trademark status. This distinction follows the October 2011 rollout of rED Cap during the BioFlorida Annual Conference.

More... »

Dendreon announces CEO and chairman succession plan

Wednesday, February 1, 2012 03:41 PM

Dendreon’s board of directors has elected John H. Johnson president and CEO, succeeding Mitchell H. Gold, M.D., who has served as both for nearly a decade.

More... »

Chiltern names new senior clinical research physicians

Wednesday, February 1, 2012 03:40 PM

Global CRO Chiltern International has hired widely-published Drs. Marcelo Piccirillo and Carlo Lanza, bringing expertise in gastroenterology, oncology and pediatrics to Chiltern.

More... »